RARA CRAFT DATABASE for FDA Medical Devices
510(k)K201724

FDA DEVICE FACTS

Pentacam AXL Wave

Oculus Optikgerate GmbH

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEOctober 21, 2020PRODUCT CODEMXK

Indications for use

The Pentacam AXL Wave is intended to image the anterior segment of the eye which includes the cornea, pupil, anterior chamber and lens. It is indicated for the evaluation of

- corneal shape,

- condition of the lens (opaque crystalline lens),

- the anterior chamber angle,

- anterior chamber depth,

- the volume of the anterior chamber,

- anterior or posterior cortical opacity,

- the location of cataracts using cross slit imaging with densitometry,

- corneal thickness,

- axial length,

- white-to-white distance,

- optical aberrations of the eye,

- and retroillumination imaging.

The Pentacam AXL Wave also performs calculations to assist physicians in determining the power of the intraocular lens for implantation.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026